Read More

Theralink And IMAC Holdings Announce Receipt And Response To The Securities And Exchange Commission Comments On The Previously Filed Form S4; Co’s Expect To Hear Back From The Securities And Exchange Commission Within The Next 10 Business Days

Theralink Technologies, Inc. (OTC:THER) ("Theralink"), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective

BACK